The evolutionary conundrum of pathogen mimicry

Nature Reviews Microbiology

Volumn 7, Issue 11, 2009, Pages 787-797

  Elde, Nels C ^a   Malik, Harmit S ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN RELATED PROTEIN 2-3 COMPLEX; CELLUBREVIN; CYCLIN D; INITIATION FACTOR 2ALPHA; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE R; RAB PROTEIN; RETINOBLASTOMA PROTEIN; SNARE PROTEIN; WISKOTT ALDRICH SYNDROME PROTEIN;

APOPTOSIS; BACTERIAL IMMUNITY; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CYTOSKELETON; HOST PATHOGEN INTERACTION; HUMAN; INNATE IMMUNITY; MICROBIAL IMMUNITY; MOLECULAR EVOLUTION; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS IMMUNITY;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; EVOLUTION, MOLECULAR; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MOLECULAR MIMICRY; PROTEINS; VIRUS DISEASES; VIRUSES;

EID: 70350208780     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro2222     Document Type: Review

References (110)

1. Greenbaum, B. D., Levine, A. J., Bhanot, G. & Rabadan, R. Patterns of evolution and host gene mimicry in influenza and other RNA viruses. PLoS Pathog. 4, e1000079 (2008).
2. Mercer, J. & Helenius, A. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320, 531-535 (2008).
3. Ochman, H., Lawrence, J. G. & Groisman, E. A. Lateral gene transfer and the nature of bacterial innovation. Nature 405, 299-304 (2000).
4. Koonin, E. V., Makarova, K. S. & Aravind, L. Horizontal gene transfer in prokaryotes: Quantification and classification. Annu. Rev. Microbiol. 55, 709-742 (2001).
5. Doolittle, R. F. Convergent evolution: The need to be explicit. Trends Biochem. Sci. 19, 15-18 (1994).
6. Webber, C. & Ponting, C. P. Genes and homology. Curr. Biol. 14 R332-333 (2004).
7. Stebbins, C. E. & Galan, J. E. Structural mimicry in bacterial virulence. Nature 412, 701-705 (2001).
8. Johnstone, R. A. The evolution of inaccurate mimics. Nature 418 524-526 (2002).
9. Holen, O. H. & Johnstone, R. A. The evolution of mimicry under constraints. Am. Nat. 164, 598-613 (2004).
10. McKean, K. A., Yourth, C. P., Lazzaro, B. P. & Clark, A. G. The evolutionary costs of immunological maintenance and deployment. BMC Evol. Biol. 8, 76 (2008).
11. van Boven, M. & Weissing, F. J. The evolutionary economics of immunity. Am. Nat. 163, 277-294 (2004).
12. OhAinle, M., Kerns, J. A., Li, M. M., Malik, H. S. & Emerman, M. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe 4, 249-259 (2008).
13. Dyer, M. D., Murali, T. M. & Sobral, B. W. The landscape of human proteins interacting with viruses and other pathogens. PLoS Pathog. 4, e32 (2008).
14. Cuconati, A. & White, E. Viral homologs of BCL-2: Role of apoptosis in the regulation of virus infection. Genes Dev. 16, 2465-2478 (2002).
15. Shackelton, L. A. & Holmes, E. C. The evolution of large DNA viruses: combining genomic information of viruses and their hosts. Trends Microbiol. 12, 458-465 (2004).
16. Gangappa, S., van Dyk, L. F., Jewett, T. J., Speck, S. H. & Virgin, H. W. Identification of the in vivo role of a viral Bcl-2. J. Exp. Med. 195, 931-940 (2002).
17. Huang, Q., Petros, A. M., Virgin, H. W., Fesik, S. W. & Olejniczak, E. T. Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2. J. Mol. Biol. 332, 1123-1130 (2003).
18. Loh, J. et al. A surface groove essential for viral Bcl-2 function during chronic infection in vivo. PLoS Pathog. 1, e10 (2005).
19. Galindo, I., Hernaez, B., Diaz-Gil, G., Escribano, J. M. & Alonso, C. A179L, a viral Bcl-2 homologue, targets the core Bcl-2 apoptotic machinery and its upstream BH3 activators with selective binding restrictions for Bid and Noxa. Virology 375, 561-72 (2008).
20. Cooray, S. et al. Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J. Gen. Virol. 88, 1656-1666 (2007).
21. Graham, S. C. et al. Vaccinia virus proteins A52 and B14 share a Bcl-2-like fold but have evolved to inhibit NF-κB rather than apoptosis. PLoS Pathog. 4, e1000128 (2008).
22. Ku, B. et al. Structural and biochemical bases for the inhibition of autophagy and apoptosis by viral BCL-2 of murine γ-herpesvirus 68. PLoS Pathog. 4, e25 (2008).
23. Westphal, D. et al. A novel Bcl-2-like inhibitor of apoptosis is encoded by the parapoxvirus ORF virus. J. Virol. 81, 7178-7188 (2007).
24. Kvansakul, M. et al. A structural viral mimic of prosurvival Bcl-2: A pivotal role for sequestering proapoptotic Bax and Bak. Mol. Cell 25, 933-942 (2007).
25. Gubser, C. et al. A new inhibitor of apoptosis from vaccinia virus and eukaryotes. PLoS Pathog. 3, e17 (2007).
26. Laman, H., Mann, D. J. & Jones, N. C. Viral-encoded cyclins. Curr. Opin. Genet. Dev. 10, 70-74 (2000).
27. Moore, P. S. & Chang, Y. Antiviral activity of tumorsuppressor pathways: clues from molecular piracy by KSHV. Trends Genet. 14, 144-150 (1998).
28. Tarakanova, V. L., Kreisel, F., White, D. W. & Virgin, H. W. Murine gammaherpesvirus 68 genes both induce and suppress lymphoproliferative disease. J. Virol. 82, 1034-1039 (2008).
29. Verschuren, E. W., Jones, N. & Evan, G. I. The cell cycle and how it is steered by Kaposi's sarcomaassociated herpesvirus cyclin. J. Gen. Virol. 85, 1347-1361 (2004).
30. Upton, J. W., van Dyk, L. F. & Speck, S. H. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks. Virology 341, 271-283 (2005).
31. Swanton, C., Card, G. L., Mann, D., McDonald, N. & Jones, N. Overcoming inhibitions: Subversion of CKI function by viral cyclins. Trends Biochem. Sci. 24, 116-120 (1999).
32. Koopal, S. et al. Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis. PLoS Pathog. 3, 1348-1360 (2007).
33. Wenner, M. Virus in the brain. Sci. Am. 300, 18-21 (2009)
34. Hume, A. J. et al. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 320, 797-799 (2008).
35. Romaker, D. et al. Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation. J. Med. Chem. 49, 7044-7053 (2006).
36. Hamirally, S. et al. Viral mimicry of Cdc2/cyclindependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress. PLoS Pathog. 5, e1000275 (2009).
37. Fischer, S. F. et al. Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3only proteins. J. Exp. Med. 200 905-916 (2004).
38. Lambrechts, A., Gevaert, K., Cossart, P., Vandekerckhove, J. & Van Troys, M. Listeria comet tails: The actin-based motility machinery at work. Trends Cell Biol. 18, 220-227 (2008).
39. Jeng, R. L. et al. A Rickettsia WASP-like protein activates the Arp2/3 complex and mediates actinbased motility. Cell. Microbiol. 6, 761-769 (2004).
40. Gouin, E. et al. The RickA protein of Rickettsia conorii activates the Arp2/3 complex. Nature 427, 457-461 (2004).
41. U hijacks actin polymerization using mimicry and multivalency. Nature 454, 1005-1008 (2008).
42. U. Nature 454, 1009-1013 (2008).
43. Stebbins, C. E. & Galan, J. E. Modulation of host signalling by a bacterial mimic: Structure of the Salmonella effector SptP bound to Rac1. Mol. Cell 6, 1449-1460 (2000).
44. Buchwald, G. et al. Structural basis for the reversible activation of a Rho protein by the bacterial toxin SopE. EMBO J. 21, 3286-3295 (2002).
45. Alto, N. M. et al. Identification of a bacterial type III effector family with G protein mimicry functions. Cell 124, 133-145 (2006).
46. Alto, N. M. & Dixon, J. E. Analysis of Rho-GTPase mimicry by a family of bacterial type III effector proteins. Methods Enzymol. 439, 131-143 (2008).
47. Ohlson, M. B. et al. Structure and function of Salmonella SifA indicate that its interactions with SKIP, SseJ, and RhoA family GTPases induce endosomal tubulation. Cell Host Microbe 4, 434-446 (2008).
48. Jackson, L. K., Nawabi, P., Hentea, C., Roark, E. A. & Haldar, K. The Salmonella virulence protein SifA is a G protein antagonist. Proc. Natl Acad. Sci. USA 105, 14141-14146 (2008).
49. Frischknecht, F. & Way, M. Surfing pathogens and the lessons learned for actin polymerization. Trends Cell Biol. 11, 30-38 (2001).
50. Valderrama, F., Cordeiro, J. V., Schleich, S., Frischknecht, F. & Way, M. Vaccinia virus-induced cell motility requires F11L-mediated inhibition of RhoA signalling. Science 311, 377-381 (2006).
51. Arakawa, Y., Cordeiro, J. V., Schleich, S., Newsome, T. P. & Way, M. The release of vaccinia virus from infected cells requires RhoA-mDia modulation of cortical actin. Cell Host Microbe 1, 227-240 (2007).
52. Arakawa, Y., Cordeiro, J. V. & Way, M. F11L-mediated inhibition of RhoA-mDia signalling stimulates microtubule dynamics during vaccinia virus infection. Cell Host Microbe 1, 213-226 (2007).
53. Favoreel, H. W., Enquist, L. W. & Feierbach, B. Actin and Rho GTPases in herpesvirus biology. Trends Microbiol. 15, 426-433 (2007).
54. Goley, E. D. et al. Dynamic nuclear actin assembly by Arp2/3 complex and a baculovirus WASP-like protein. Science 314, 464-467 (2006).
55. Delevoye, C. et al. SNARE protein mimicry by an intracellular bacterium. PLoS Pathog. 4, e1000022 (2008).
56. Rockey, D. D., Viratyosin, W., Bannantine, J. P., Suchland, R. J. & Stamm, W. E. Diversity within inc genes of clinical Chlamydia trachomatis variant isolates that occupy nonfusogenic inclusions. Microbiology 148, 2497-2505 (2002).
57. Ingmundson, A., Delprato, A., Lambright, D. G. & Roy., C. R. Legionella pneumophila proteins that regulate Rab1 membrane cycling. Nature 450, 365-369 (2007).
58. Murata, T. et al. The Legionella pneumophila effector protein DrrA is a Rab1 guanine nucleotide-exchange factor. Nature Cell Biol. 8, 971-977 (2006).
59. Grosshans, B. L., Ortiz, D. & Novick, P. Rabs and their effectors: achieving specificity in membrane traffic. Proc. Natl Acad. Sci. USA 103, 11821-11827 (2006).
60. Shin, S. & Roy., C. R. Host cell processes that influence the intracellular survival of Legionella pneumophila. Cell. Microbiol. 10, 1209-1220 (2008).
61. Shah, A. H., Cianciola, N. L., Mills, J. L., Sonnichsen, F. D. & Carlin, C. Adenovirus RIDα regulates endosome maturation by mimicking GTP-Rab7. J. Cell Biol. 179, 965-980 (2007).
62. Alto, N. M. Mimicking small G-proteins: An emerging theme from the bacterial virulence arsenal. Cell. Microbiol. 10, 566-575 (2008).
63. Finlay, B. B. & McFadden, G. Anti-immunology: Evasion of the host immune system by bacterial and viral pathogens. Cell 124, 767-782 (2006).
64. Alcami, A. Viral mimicry of cytokines, chemokines and their receptors. Nature Rev. Immunol. 3, 36-50 (2003).
65. Alcami, A., Symons, J. A. & Smith, G. L. The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J. Virol. 74 11230-11239 (2000).
66. Nazarian, S. H. et al. Yaba monkey tumor virus encodes a functional inhibitor of interleukin-18. J. Virol. 82, 522-528 (2008).
67. Cameron, C. M., Barrett, J. W., Mann, M., Lucas, A. & McFadden, G. Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo. Virology 337, 155-167 (2005).
68. Ruiz-Arguello, M. B. et al. An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain. J. Virol. 82, 917-926 (2008).
69. Seet, B. T. et al. Poxviruses and immune evasion. Annu. Rev. Immunol. 21, 377-423 (2003).
70. Barrett, J. W. et al. M135R is a novel cell surface virulence factor of myxoma virus. J. Virol. 81, 106-114 (2007).
71. Cirl, C. et al. Subversion of Toll-like receptor signalling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nature Med. 14, 399-406 (2008).
72. Newman, R. M., Salunkhe, P., Godzik, A. & Reed, J. C. Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins. Infect. Immun. 74, 594-601 (2006).
73. Ha, S. C. et al. A poxvirus protein forms a complex with left-handed Z-DNA: Crystal structure of a Yatapoxvirus Zα bound to DNA. Proc. Natl Acad. Sci. USA 101, 14367-14372 (2004).
74. Kwon, J. A. & Rich, A. Biological function of the vaccinia virus Z-DNA-binding protein E3L: Gene transactivation and antiapoptotic activity in HeLa cells. Proc. Natl Acad. Sci. USA 102, 12759-12764 (2005).
75. Quyen, D. V. et al. Characterization of DNA-binding activity of Zα domains from poxviruses and the importance of the β-wing regions in converting B-DNA to Z-DNA. Nucleic Acids Res. 35, 7714-7720 (2007).
76. Romano, P. R. et al. Inhibition of double-stranded RNAdependent protein kinase PKR by vaccinia virus E3: Role of complex formation and the E3 N-terminal domain. Mol. Cell Biol. 18, 7304-7316 (1998).
77. Kawagishi-Kobayashi, M., Silverman, J. B., Ung, T. L. & Dever, T. E. Regulation of the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent on residues conserved between the K3L protein and the PKR substrate eIF2α. Mol. Cell Biol. 17, 4146-4158 (1997).
78. Kawagishi-Kobayashi, M., Cao, C., Lu, J., Ozato, K. & Dever, T. E. Pseudosubstrate inhibition of protein kinase PKR by swine pox virus C8L gene product. Virology 276, 424-34 (2000).
79. Dar, A. C., Dever, T. E. & Sicheri, F. Higher-order substrate recognition of eIF2α by the RNA-dependent protein kinase PKR. Cell 122, 887-900 (2005).
80. Dar, A. C. & Sicheri, F. X-ray crystal structure and functional analysis of vaccinia virus K3L reveals molecular determinants for PKR subversion and substrate recognition. Mol. Cell 10, 295-305 (2002).
81. Essbauer, S., Bremont, M. & Ahne, W. Comparison of the eIF-2α homologous proteins of seven ranaviruses (Iridoviridae). Virus Genes 23, 347-359 (2001).
82. Dever, T. E. et al. Disruption of cellular translational control by a viral truncated eukaryotic translation initiation factor 2α kinase homolog. Proc. Natl Acad. Sci. USA 95, 4164-4169 (1998).
83. Elde, N. C., Child., S. J., Geballe, A. P. & Malik, H. S. Protein kinase R reveals an evolutionary model for defeating viral mimicry. Nature 457, 485-489 (2009).
84. Rothenburg, S., Seo, E. J., Gibbs, J. S., Dever, T. E. & Dittmar, K. Rapid evolution of protein kinase PKR alters sensitivity to viral inhibitors. Nature Struct. Mol. Biol. 16, 63-70 (2009).
85. Ochs, H. D., Filipovich, A. H., Veys, P., Cowan, M. J. & Kapoor, N. Wiskott-Aldrich syndrome: Diagnosis, clinical and laboratory manifestations, and treatment. Biol. Blood Marrow Transplant. 15, 84-90 (2008).
86. Notarangelo, L. D., Notarangelo, L. D. & Ochs, H. D. WASP and the phenotypic range associated with deficiency. Curr. Opin. Allergy Clin. Immunol. 5, 485-490 (2005).
87. Kwiatkowski, D. Genetic susceptibility to malaria getting complex. Curr. Opin. Genet. Dev. 10, 320-324 (2000).
88. Rothenburg, S., Deigendesch, N., Dey, M., Dever, T. E. & Tazi, L. Double-stranded RNA-activated protein kinase PKR of fishes and amphibians: Varying the number of double-stranded RNA binding domains and lineagespecific duplications. BMC Biol. 6, 12 (2008).
89. Nielsen, R. et al. A scan for positively selected genes in the genomes of humans and chimpanzees. PLoS Biol. 3, e170 (2005).
90. Gibbs, R. A. et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science 316, 222-234 (2007).
91. Bustamante, C. D. et al. Natural selection on proteincoding genes in the human genome. Nature 437, 1153-1157 (2005).
92. Clark, A. G. et al. Positive selection in the human genome inferred from human-chimp-mouse orthologous gene alignments. Cold Spring Harb. Symp. Quant. Biol. 68, 471-477 (2003).
93. Kaiser, S. M., Malik, H. S. & Emerman, M. Restriction of an extinct retrovirus by the human TRIM5α antiviral protein. Science 316 1756-1758 (2007).
94. Dean, A. M. & Thornton, J. W. Mechanistic approaches to the study of evolution: The functional synthesis. Nature Rev. Genet. 8, 675-688 (2007).
95. Johnson, W. E. & Sawyer, S. L. Molecular evolution of the antiretroviral TRIM5 gene. Immunogenetics 61, 163-176 (2009).
96. Huthoff, H. & Towers, G. J. Restriction of retroviral replication by APOBEC3G/F and TRIM5α. Trends Microbiol. 16, 612-619 (2008).
97. Ruxton, G. D., Sherratt, T. N. & Speed, M. P. Avoiding Attack: The Evolutionary Ecology of Crypsis, Warning Signals and Mimicry (Oxford University Press, New York, 2004).
98. Barber, J. R. & Conner, W. E. Acoustic mimicry in a predator-prey interaction. Proc. Natl Acad. Sci. USA 104, 9331-9334 (2007).
99. Van Valen, L. A new evolutionary law. Evolutionary Theory 1, 1-30 (1973).
100. Goff, S. P. Retrovirus restriction factors. Mol. Cell 16, 849-859 (2004).
101. Yan, Y., Buckler-White, A., Wollenberg, K. & Kozak, C. A. Origin, antiviral function and evidence for positive selection of the gammaretrovirus restriction gene Fv1 in the genus Mus. Proc. Natl Acad. Sci. USA, 106, 3259-3263 (2009).
102. Arnaud, F. et al. A paradigm for virus-host coevolution: sequential counter-adaptations between endogenous and exogenous retroviruses. PLoS Pathog. 3, e170 (2007).
103. Malik, H. S. & Henikoff, S. Positive selection of Iris, a retroviral envelope-derived host gene in Drosophila melanogaster. PLoS Genet. 1, e44 (2005).
104. Rawn, S. M. & Cross, J. C. The evolution, regulation, and function of placenta-specific genes. Annu. Rev. Cell Dev. Biol. 24, 159-181 (2008).
105. Stoltz, D. B. & Whitfield, J. B. Virology. Making nice with viruses. Science 323, 884-885 (2009).
106. Bezier, A. et al. Polydnaviruses of braconid wasps derive from an ancestral nudivirus. Science 323, 926-930 (2009).
107. Wurtele, M. et al. How the Pseudomonas aeruginosa ExoS toxin downregulates Rac. Nature Struct. Biol. 8, 23-26 (2001).
108. Colinet, D., Schmitz, A., Depoix, D., Crochard, D. & Poirie, M. Convergent use of RhoGAP toxins by eukaryotic parasites and bacterial pathogens. PLoS Pathog. 3, e203 (2007).
109. Rittinger, K., Walker, P. A., Eccleston, J. F., Smerdon, S. J. & Gamblin, S. J. Structure at 1.65 Å of RhoA and its GTPase-activating protein in complex with a transitionstate analogue. Nature 389 758-762 (1997).
110. Stack, J. et al. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 201, 1007-1018 (2005).